Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome ; volume:9 ; number:1 ; day:20 ; month:12 ; year:2011 ; pages:1-8 ; date:12.2011
Hereditary cancer in clinical practice ; 9, Heft 1 (20.12.2011), 1-8, 12.2011
- Creator
-
Ewald, Ingrid P.
- Contributor
-
Izetti, Patrícia
Vargas, Fernando R.
Moreira, Miguel AM
Moreira, Aline S.
Moreira-Filho, Carlos A.
Cunha, Danielle R.
Hamaguchi, Sara
Camey, Suzi A.
Schmidt, Aishameriane
Caleffi, Maira
Koehler-Santos, Patrícia
Giugliani, Roberto
Ashton-Prolla, Patricia
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-9-12
- URN
-
urn:nbn:de:1111-201607101971
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ewald, Ingrid P.
- Izetti, Patrícia
- Vargas, Fernando R.
- Moreira, Miguel AM
- Moreira, Aline S.
- Moreira-Filho, Carlos A.
- Cunha, Danielle R.
- Hamaguchi, Sara
- Camey, Suzi A.
- Schmidt, Aishameriane
- Caleffi, Maira
- Koehler-Santos, Patrícia
- Giugliani, Roberto
- Ashton-Prolla, Patricia
- SpringerLink (Online service)
Other Objects (12)
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine
BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel
BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients